![](/images/general/no_picture/200_user.png)
Howard J Sanders
Examiner (ID: 15220, Phone: (571)270-3096 , Office: P/3653 )
Most Active Art Unit | 3653 |
Art Unit(s) | 3658, 3653 |
Total Applications | 914 |
Issued Applications | 683 |
Pending Applications | 65 |
Abandoned Applications | 166 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16483840
[patent_doc_number] => 20200377441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => METHODS OF PROTECTING AN ORGAN USING TETRAHYDROCURCUMIN AND PHOSPHATIDYLCHOLINE
[patent_app_type] => utility
[patent_app_number] => 16/997255
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997255
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/997255 | METHODS OF PROTECTING AN ORGAN USING TETRAHYDROCURCUMIN AND PHOSPHATIDYLCHOLINE | Aug 18, 2020 | Pending |
Array
(
[id] => 17697071
[patent_doc_number] => 11370781
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Combination therapy for treating cancer
[patent_app_type] => utility
[patent_app_number] => 16/985404
[patent_app_country] => US
[patent_app_date] => 2020-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 38794
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 291
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16985404
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/985404 | Combination therapy for treating cancer | Aug 4, 2020 | Issued |
Array
(
[id] => 16569091
[patent_doc_number] => 20210008097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => Compositions Comprising Galactose-Pronged Polysaccharides
[patent_app_type] => utility
[patent_app_number] => 16/983760
[patent_app_country] => US
[patent_app_date] => 2020-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8465
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16983760
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/983760 | Compositions Comprising Galactose-Pronged Polysaccharides | Aug 2, 2020 | Abandoned |
Array
(
[id] => 17620149
[patent_doc_number] => 11339187
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-24
[patent_title] => Process for the preparation of GalNAc oligonucleotide conjugates
[patent_app_type] => utility
[patent_app_number] => 16/939849
[patent_app_country] => US
[patent_app_date] => 2020-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5916
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16939849
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/939849 | Process for the preparation of GalNAc oligonucleotide conjugates | Jul 26, 2020 | Issued |
Array
(
[id] => 16437071
[patent_doc_number] => 20200354397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => PHOSPHORAMIDITE SYNTHONES FOR THE SYNTHESIS OF SELF-NEUTRALIZING OLIGONUCLEOTIDE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/940039
[patent_app_country] => US
[patent_app_date] => 2020-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16940039
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/940039 | Phosphoramidite synthones for the synthesis of self-neutralizing oligonucleotide compounds | Jul 26, 2020 | Issued |
Array
(
[id] => 16619976
[patent_doc_number] => 20210038629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => COMPOUNDS AND METHODS FOR MODULATING GFAP
[patent_app_type] => utility
[patent_app_number] => 16/938826
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16938826
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/938826 | Compounds and methods for modulating GFAP | Jul 23, 2020 | Issued |
Array
(
[id] => 16569083
[patent_doc_number] => 20210008089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER
[patent_app_type] => utility
[patent_app_number] => 16/929690
[patent_app_country] => US
[patent_app_date] => 2020-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16929690
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/929690 | COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER | Jul 14, 2020 | Abandoned |
Array
(
[id] => 16791669
[patent_doc_number] => 20210121486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/921562
[patent_app_country] => US
[patent_app_date] => 2020-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50325
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16921562
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/921562 | ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE | Jul 5, 2020 | Abandoned |
Array
(
[id] => 16523727
[patent_doc_number] => 20200397807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => NICOTINYL RIBOSIDE COMPOUNDS AND THEIR USES
[patent_app_type] => utility
[patent_app_number] => 16/904270
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904270
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/904270 | NICOTINYL RIBOSIDE COMPOUNDS AND THEIR USES | Jun 16, 2020 | Abandoned |
Array
(
[id] => 17421482
[patent_doc_number] => 11254927
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Polynucleotide capture materials, and systems using same
[patent_app_type] => utility
[patent_app_number] => 16/890752
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13461
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16890752
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/890752 | Polynucleotide capture materials, and systems using same | Jun 1, 2020 | Issued |
Array
(
[id] => 16297823
[patent_doc_number] => 20200283546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => Method for Preparing Short-Clustered Dextrin
[patent_app_type] => utility
[patent_app_number] => 16/884340
[patent_app_country] => US
[patent_app_date] => 2020-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5591
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16884340
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/884340 | Method for preparing short-clustered dextrin | May 26, 2020 | Issued |
Array
(
[id] => 17828388
[patent_doc_number] => 20220265692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => ORALLY-ADMINISTERED PHARMACEUTICAL COMPOSITION FOR ERADICATING ANTIBIOTIC-RESISTANT HELICOBACTER PYLORI, COMPRISING COMPLEX OF NON-ABSORBABLE ANTIBIOTIC AND CLAY MINERAL
[patent_app_type] => utility
[patent_app_number] => 17/620585
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620585
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/620585 | ORALLY-ADMINISTERED PHARMACEUTICAL COMPOSITION FOR ERADICATING ANTIBIOTIC-RESISTANT HELICOBACTER PYLORI, COMPRISING COMPLEX OF NON-ABSORBABLE ANTIBIOTIC AND CLAY MINERAL | May 21, 2020 | Pending |
Array
(
[id] => 16282615
[patent_doc_number] => 20200276217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => Application of Macrolide Antibiotic in Blocking Influenza Virus Infection
[patent_app_type] => utility
[patent_app_number] => 16/880414
[patent_app_country] => US
[patent_app_date] => 2020-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5691
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16880414
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/880414 | Application of Macrolide Antibiotic in Blocking Influenza Virus Infection | May 20, 2020 | Abandoned |
Array
(
[id] => 16268723
[patent_doc_number] => 20200270210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => CHEMICAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/872949
[patent_app_country] => US
[patent_app_date] => 2020-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16872949
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/872949 | Chemical compounds | May 11, 2020 | Issued |
Array
(
[id] => 16583168
[patent_doc_number] => 20210017570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => DETECTION OF OLIGOSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 16/866397
[patent_app_country] => US
[patent_app_date] => 2020-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22418
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16866397
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/866397 | DETECTION OF OLIGOSACCHARIDES | May 3, 2020 | Abandoned |
Array
(
[id] => 16435643
[patent_doc_number] => 20200352968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => METHODS FOR REDUCING THE WEIGHT LOSS OR INCREASING THE WEIGHT OF A FELINE IN NEED THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/856342
[patent_app_country] => US
[patent_app_date] => 2020-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12722
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16856342
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/856342 | METHODS FOR REDUCING THE WEIGHT LOSS OR INCREASING THE WEIGHT OF A FELINE IN NEED THEREOF | Apr 22, 2020 | Abandoned |
Array
(
[id] => 16688741
[patent_doc_number] => 20210071217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => GELLING DEXTRAN ETHERS
[patent_app_type] => utility
[patent_app_number] => 16/856559
[patent_app_country] => US
[patent_app_date] => 2020-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36648
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16856559
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/856559 | GELLING DEXTRAN ETHERS | Apr 22, 2020 | Abandoned |
Array
(
[id] => 16452917
[patent_doc_number] => 20200362343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT
[patent_app_type] => utility
[patent_app_number] => 16/853670
[patent_app_country] => US
[patent_app_date] => 2020-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45840
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16853670
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/853670 | METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT | Apr 19, 2020 | Abandoned |
Array
(
[id] => 16204804
[patent_doc_number] => 20200237794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS
[patent_app_type] => utility
[patent_app_number] => 16/844522
[patent_app_country] => US
[patent_app_date] => 2020-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19148
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16844522
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/844522 | TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS | Apr 8, 2020 | Pending |
16/838972 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | Apr 1, 2020 |